Healthcare

Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in...

DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved

Medi-Ops and Southwest Transplant Alliance Successfully Complete One of the First Commercial On-Board Courier Flights with Paragonix KidneyVault

Innovative Collaboration Enables Long-Distance Organ Transports, Expanding Access to Life-Saving Kidney Transplants DALLAS, March 27, 2025 /PRNewswire/ -- Medi-Ops, a...

Single-cell Analysis Market Surges to USD 5.4 Billion by 2033, Propelled by 9.5% CAGR – Verified Market Reports®

The Single-Cell Analysis Market is experiencing robust expansion, driven by surging demand for precision medicine, advancements in genomics, and rising investments...

error: Content is protected !!